ZA200500326B - Method for identifying substances - Google Patents

Method for identifying substances

Info

Publication number
ZA200500326B
ZA200500326B ZA200500326A ZA200500326A ZA200500326B ZA 200500326 B ZA200500326 B ZA 200500326B ZA 200500326 A ZA200500326 A ZA 200500326A ZA 200500326 A ZA200500326 A ZA 200500326A ZA 200500326 B ZA200500326 B ZA 200500326B
Authority
ZA
South Africa
Prior art keywords
identifying substances
activity
cell
cell replication
identifying
Prior art date
Application number
ZA200500326A
Other languages
English (en)
Inventor
Sabine Gratzer
Meltsje De Hoop
Bernhard Mai
Original Assignee
Sanoa Aventis Deustchland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanoa Aventis Deustchland Gmbh filed Critical Sanoa Aventis Deustchland Gmbh
Publication of ZA200500326B publication Critical patent/ZA200500326B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/395Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Saccharomyces
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
ZA200500326A 2002-07-23 2005-01-13 Method for identifying substances ZA200500326B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10233516A DE10233516A1 (de) 2002-07-23 2002-07-23 Verfahren zur Identifizierung von Substanzen

Publications (1)

Publication Number Publication Date
ZA200500326B true ZA200500326B (en) 2006-07-26

Family

ID=30128304

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200500326A ZA200500326B (en) 2002-07-23 2005-01-13 Method for identifying substances

Country Status (17)

Country Link
US (1) US8642259B2 (fr)
EP (1) EP1527340B1 (fr)
JP (1) JP4546827B2 (fr)
KR (1) KR101089048B1 (fr)
CN (1) CN100397078C (fr)
AT (1) ATE447176T1 (fr)
AU (1) AU2003260308B2 (fr)
BR (1) BR0312804A (fr)
CA (1) CA2493323C (fr)
DE (2) DE10233516A1 (fr)
HK (1) HK1083534A1 (fr)
IL (1) IL166345A (fr)
MX (1) MXPA05000837A (fr)
NO (1) NO20050919L (fr)
RU (1) RU2325652C2 (fr)
WO (1) WO2004019036A2 (fr)
ZA (1) ZA200500326B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060246417A1 (en) * 2005-04-30 2006-11-02 Ok-Kyu Song System for functional analysis of polypeptides
FR3069644B1 (fr) * 2017-07-28 2024-07-12 Cisbio Bioassays Methode pour mesurer la modulation de l'activation d'un recepteur couple a une proteine g

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3429823A1 (de) * 1984-08-14 1986-02-27 Merck Patent Gmbh, 6100 Darmstadt Mittel und verfahren zum nachweis antimikrobiell wirksamer substanzen
US5885769A (en) * 1991-02-14 1999-03-23 Schering Corporation Screening systems
IL110298A (en) 1993-07-13 1999-04-11 Brann Mark Robert Identification of ligands by selective amplification of cells transfected with receptors
US5691188A (en) 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
US5728534A (en) * 1996-07-19 1998-03-17 New England Medical Center Hospitals, Inc. Methods for identifying cardiovascular therapeutic agents
CN1107870C (zh) * 1996-09-20 2003-05-07 奥索·麦克尼尔药品公司 用于体外测定红细胞生成素生物活性的方法及其试剂盒
WO1998016557A1 (fr) * 1996-10-11 1998-04-23 The General Hospital Corporation Dosages pour recepteurs lies a la proteine g
GB9719496D0 (en) * 1997-09-13 1997-11-19 Glaxo Group Ltd G protien chimeras
EP0974649A1 (fr) * 1998-06-22 2000-01-26 Universität Zürich Système de criblage
AU756244B2 (en) * 1998-09-01 2003-01-09 Basf Aktiengesellschaft Methods for improving the function of heterologous G protein-coupled receptors
US6063578A (en) * 1998-10-22 2000-05-16 Signal Pharmaceuticals, Inc. Dual reporter system and methods of use therefor
DE10056899A1 (de) * 2000-11-16 2002-05-29 Aventis Pharma Gmbh Promotor zur funktionellen Charakterisierung von G-Protein gekoppelten Rezeptoren in der Hefe Saccharomyces cerevisiae
US20050118690A1 (en) * 2001-10-09 2005-06-02 Shannon Roberts Love variant regulator molecules

Also Published As

Publication number Publication date
EP1527340A2 (fr) 2005-05-04
ATE447176T1 (de) 2009-11-15
EP1527340B1 (fr) 2009-10-28
RU2005104955A (ru) 2005-10-10
KR20050025648A (ko) 2005-03-14
IL166345A (en) 2011-11-30
RU2325652C2 (ru) 2008-05-27
US20040092474A1 (en) 2004-05-13
DE10233516A1 (de) 2004-02-12
CN1672046A (zh) 2005-09-21
JP2005533523A (ja) 2005-11-10
MXPA05000837A (es) 2005-04-19
NO20050919L (no) 2005-04-14
WO2004019036A3 (fr) 2004-05-13
CA2493323A1 (fr) 2004-03-04
WO2004019036A2 (fr) 2004-03-04
HK1083534A1 (en) 2006-07-07
CA2493323C (fr) 2012-04-17
JP4546827B2 (ja) 2010-09-22
BR0312804A (pt) 2005-04-19
CN100397078C (zh) 2008-06-25
AU2003260308B2 (en) 2009-03-26
KR101089048B1 (ko) 2011-12-02
IL166345A0 (en) 2006-01-16
AU2003260308A1 (en) 2004-03-11
US8642259B2 (en) 2014-02-04
DE50312072D1 (de) 2009-12-10

Similar Documents

Publication Publication Date Title
AU2003261168A1 (en) Strategies for gene expression analysis
DE60028732D1 (de) Verfahren zur erhaltung der dns-integrität
WO2003062462A3 (fr) Methode permettant d'isoler des acides nucleiques et des proteines contenus dans un echantillon unique
WO2007073171A3 (fr) Strategies ameliorees pour etablir des profils de produits de transcription au moyen de technologies de sequençage a rendement eleve
ATE210192T1 (de) VERFAHREN ZUR DIREKTEN SEQUENZIERUNG WÄHREND ßTEMPLATEß-AMPLIFIKATION
ATE381552T1 (de) Derivate von 1-piperazin- und 1- homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
WO2005042692A3 (fr) Methode permettant d'inhiber l'expression de genes qui induisent l'influx de cholesterol cellulaire dans les cellules animales et d'inhiber la production de proteines issues de l'expression de ces genes
WO2003048300A3 (fr) Procedes d'identification de molecules cibles cellulaires
AU2003301322A1 (en) Apparatus for introducing biological material, method of introducing biological material and magnetic support for introducing biological material
WO1999050459A3 (fr) Essais in vitro a haut rendement pour la recherche systematique de modulateurs de transcription
HK1083534A1 (en) Method for identifying substances
WO2005028621A3 (fr) Essais biologiques sur des cellules primaires
EP1647818A3 (fr) Pseudo-tissu pour le contrôle-qualité, et méthode pour le contrôle-qualité utilisant ledit tissu
WO2005019475A3 (fr) Proteine 2 inductible par l'hypoxie (hig2), nouvelle cible therapeutique potentielle de l'hypernephrome (rcc)
AU2003257133A1 (en) Methods, devices and kits for multiplex blotting of biological samples from multi-well plates
WO2001042503A3 (fr) Appareil et methodes de criblage de medicaments
WO1999039009A8 (fr) Procedes permettant d'isoler, d'amplifier et de caracteriser un adn
WO2002037077A3 (fr) Techniques de criblage reposant sur un systeme d'analyse de regulation transcriptionnelle au moyen de lignees cellulaires transformees
WO2005023985A3 (fr) Activateurs de cytidine-desaminase, activateurs de desoxycytidine-desaminase, antagonistes du vif et procedes de criblage des molecules correspondantes
AU2003285775A1 (en) Method for identifying, analyzing and/or cloning nucleic acid isoforms
AU2003257569A1 (en) Culture system, detection and analysis system and detection method for cancer cell colonies
ATE323173T1 (de) Nährboden zum nachweis und/oder zur unterscheidung von enterokokken
AU2003241174A1 (en) Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc
DE59907009D1 (de) Vorrichtung zum beschichten von plattenförmigen substraten